Sun Pharma expects normalisation of India business in FY'19 0 02.10.2018 15:12 Economictimes.indiatimes.com Sun Pharma MD Dilip Shanghvi said the government's enforced price cuts and policy changes are potential risk factors for the business. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
